Keywords: freedox, rejected, fda, panel, second, sitting, pharmacia

P&U's Freedox rejected by FDA panel at second sitting

Article | 06 May 1999

Print This

Pharmacia & Upjohn's lazaroid drug Freedox (tirilazad mesylate) hasfailed to win a recommendation for approval from a US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in